Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Incidence, Management, and Immediate- and Long-Term Outcomes After Iatrogenic Aortic Dissection During Diagnostic or Interventional Coronary Procedures.

Núñez-Gil IJ, Bautista D, Cerrato E, Salinas P, Varbella F, Omedè P, Ugo F, Ielasi A, Giammaria M, Moreno R, Pérez-Vizcayno MJ, Escaned J, De Agustin JA, Feltes G, Macaya C, Fernández-Ortiz A; Registry on Aortic Iatrogenic Dissection (RAID) Investigators.

Circulation. 2015 Jun 16;131(24):2114-9. doi: 10.1161/CIRCULATIONAHA.115.015334. Epub 2015 Apr 17.

PMID:
25888682
2.

[Two catheters for one coronary perforation].

Barbieri L, Verdoia M, Schaffer A, Marino P, De Luca G.

G Ital Cardiol (Rome). 2015 Feb;16(2):112-5. doi: 10.1714/1798.19588. Italian.

PMID:
25805096
3.

Permanent polymer of drug eluting stents increases eosinophil cationic protein levels following percutaneous coronary intervention independently of C-reactive protein.

Niccoli G, Calvieri C, Minelli S, Copponi G, Montone RA, Imaeva A, Roberto M, Cosentino N, Crea F.

Atherosclerosis. 2014 Dec;237(2):816-20. doi: 10.1016/j.atherosclerosis.2014.11.002. Epub 2014 Nov 6. Erratum in: Atherosclerosis. 2015 Feb;238(2)239. Montone, Rocco [corrected to Montone, Rocco A].

PMID:
25463127
4.

Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic study.

Cayla G, Cuisset T, Silvain J, Henry P, Leclercq F, Carrié D, Etienne CS, Belle L, Rangé G, Pouillot C, Varenne O, Van Belle E, Boueri Z, Motreff P, Elhadad S, Delarche N, El Mahmoud R, Vicaut E, Collet JP, Montalescot G; ANTARCTIC investigators.

Am Heart J. 2014 Nov;168(5):674-81. doi: 10.1016/j.ahj.2014.07.026. Epub 2014 Aug 7.

PMID:
25440795
5.

Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.

Berta B, Jambrik Z, Kohar K, Szabo G, Ruzsa Z, Molnar L, Barczi G, Geller L, Becker D, Merkely B.

Hellenic J Cardiol. 2014 Sep-Oct;55(5):369-77.

6.

Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).

Valgimigli M, Tricoci P, Huang Z, Aylward PE, Armstrong PW, Van de Werf F, Leonardi S, White HD, Widimsky P, Harrington RA, Cequier A, Chen E, Lokhnygina Y, Wallentin L, Strony J, Mahaffey KW, Moliterno DJ.

Am J Cardiol. 2014 Sep 1;114(5):665-73. doi: 10.1016/j.amjcard.2014.05.054. Epub 2014 Jun 18.

PMID:
25129064
7.

Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome?

Christodoulidis G, Baber U, Mehran R.

Curr Opin Cardiol. 2014 Jul;29(4):301-6. doi: 10.1097/HCO.0000000000000070. Review.

PMID:
24842783
8.

Impact of albuminuria on the incidence of periprocedural myocardial injury in patients undergoing elective coronary stent implantation.

Osugi N, Suzuki S, Ishii H, Yasuda Y, Shibata Y, Tatami Y, Ota T, Kawamura Y, Okumura S, Tanaka A, Inoue Y, Matsuo S, Murohara T.

Am J Cardiol. 2014 Jul 1;114(1):42-6. doi: 10.1016/j.amjcard.2014.03.058. Epub 2014 Apr 18.

PMID:
24802297
9.

[Registry of non-ST elevation acute coronary syndromes in a tertiary hospital (RESCATA-SEST registry)].

González-Pliego JA, Gutiérrez-Díaz GI, Celis A, Gudiño-Amezcua DA.

Arch Cardiol Mex. 2014 Apr-Jun;84(2):92-9. doi: 10.1016/j.acmx.2013.11.006. Epub 2014 May 1. Spanish.

PMID:
24793555
10.

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis.

Demyanets S, Tentzeris I, Jarai R, Katsaros KM, Farhan S, Wonnerth A, Weiss TW, Wojta J, Speidl WS, Huber K.

Cytokine. 2014 Jun;67(2):65-70. doi: 10.1016/j.cyto.2014.02.014. Epub 2014 Mar 27.

11.

Friable coronary arteries are link between pathogenesis and treatment of spontaneous coronary artery dissection.

Vanhaverbeke M, Sarens T, Driessche LV.

Acta Clin Belg. 2014 Jun;69(3):217-20. doi: 10.1179/2295333714Y.0000000020. Epub 2014 Apr 8.

PMID:
24712892
12.

Myocardial hydrophilic polymer emboli following cardiac catheterization: a case report and literature review.

Rosen LE, Singh RI, Mahon B.

Cardiovasc Pathol. 2014 May-Jun;23(3):175-7. doi: 10.1016/j.carpath.2014.01.009. Epub 2014 Feb 4. Review.

PMID:
24666841
13.

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation. Intracoronary Stenting and Antithrombotic Regimen: CAUTION in Discontinuing Clopidogrel Therapy--ISAR-CAUTION.

Fiedler KA, Mehilli J, Kufner S, Schlichting A, Ibrahim T, Sibbing D, Ott I, Schunkert H, Laugwitz KL, Kastrati A, Schulz S.

Thromb Haemost. 2014 Jun;111(6):1041-9. doi: 10.1160/TH13-11-0900. Epub 2014 Mar 13.

PMID:
24633406
14.

Choosing the right coronary stent in the modern era.

Toklu B, Bangalore S.

Curr Cardiol Rep. 2014 Apr;16(4):469. doi: 10.1007/s11886-014-0469-4. Review.

PMID:
24604695
15.

Acute coronary ischemia identified by EMS providers in a standing middle-aged male with atypical symptoms.

Ross DW, Cooperrider C, Homan MB.

Prehosp Emerg Care. 2014 Jul-Sep;18(3):450-5. doi: 10.3109/10903127.2014.883000. Epub 2014 Mar 6.

PMID:
24601873
16.

Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.

Généreux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, Xu K, McAndrew T, Kirtane A, Lansky AJ, Brener SJ, Mehran R, Stone GW.

J Am Coll Cardiol. 2014 May 13;63(18):1845-54. doi: 10.1016/j.jacc.2014.01.034. Epub 2014 Feb 19.

17.

Update in therapeutic approaches to plaque stabilization.

Nicholls SJ, Kataoka Y.

Curr Atheroscler Rep. 2014 Mar;16(3):392. doi: 10.1007/s11883-013-0392-y. Review.

PMID:
24425061
18.

Elutax paclitaxel-eluting balloon followed by bare-metal stent compared with Xience V drug-eluting stent in the treatment of de novo coronary stenosis: a randomized trial.

Liistro F, Porto I, Angioli P, Grotti S, Ducci K, Falsini G, Bolognese L.

Am Heart J. 2013 Nov;166(5):920-6. doi: 10.1016/j.ahj.2013.08.023. Epub 2013 Oct 7.

PMID:
24176449
19.

Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.

Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, Kirtane A, Siller-Matula J, Mahla E, Becker RC, Bhatt DL, Waksman R, Rao SV, Alexopoulos D, Marcucci R, Reny JL, Trenk D, Sibbing D, Gurbel PA; Working Group on On-Treatment Platelet Reactivity.

J Am Coll Cardiol. 2013 Dec 17;62(24):2261-73. doi: 10.1016/j.jacc.2013.07.101. Epub 2013 Sep 27.

20.

Exercise training is safe after coronary stenting: a prospective multicentre study.

Iliou MC, Pavy B, Martinez J, Corone S, Meurin P, Tuppin P; CRS investigators and GERS (Groupe Exercice Réadaptation, Sport) from French Society of Cardiology.

Eur J Prev Cardiol. 2015 Jan;22(1):27-34. doi: 10.1177/2047487313505819. Epub 2013 Sep 20.

PMID:
24057686
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk